CORE 2 - Mass Spectrometry Core
- Institution
- UT SOUTHWESTERN MEDICAL CENTER, TX
- Principal investigator
- Jeff G Mcdonald
- Funding
- $164K
- Duration
- 2022–2027
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT – Core 2-Lipid Mass Spectrometry Core The Lipid Mass Spectrometry Core (LMSC) will draw on the strong lipid mass spectrometry culture at UT Southwestern in the Center for Human Nutrition that has been developed and is managed by Dr. Jeff McDonald to serve needs of UT Southwestern NORC investigators. Through an extensive suite of instruments in the Center along with significant experience and knowledge in all aspects of mass spectrometry-based lipid analysis, the goal of this Core is to support all NORC investigators to provide lipid measurements needed relevant to their NORC research projects. The three primary objectives of the LMSC are: 1) Provide quantitative analysis of targeted lipid classes that include fatty acids, sterols/oxysterols, bile acids, steroids, eicosanoids, and sphingolipids; 2) Provide untargeted, relative lipidomic analysis that covers the major classes of lipids including steryl esters, glycerolipids, phospholipids, and sphingolipids; and 3) Develop novel methods to support unique needs of NORC investigators. The services and capabilities provided by the LMSC cover almost all aspects of lipid analysis from extraction to analysis to data interpretation and dissemination. The LMSC has proven capabilities from effectively handling large cohorts (clinical and research) for targeted lipid analysis to broad exploratory work on small pilot projects.
LOADING MOONBASE SCORE
Questions for UT SOUTHWESTERN MEDICAL CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · UT Southwestern Medical CenterNot yet scored
Lipid Mass Spectrometry
Jeff G Mcdonald · $273K · 2022–2026
- NIH · UT Southwestern Medical Center61
Validation of Spinal Neurotensin Receptor 2 as an Analgesic Target
Amol M Patwardhan · $397K · 2020–2026
- NIH · UT Southwestern Medical Center58
Role of histotripsy synergized CD40 signaling in the re-engineering of cold tumors
Ashish Ranjan · $504K · 2022–2028